Guy Charles Fanneau de La Horie
Signal active
CEO
Contact Information
Social
Primary Organization
Pherecydes Pharma
Founded
2006
Employees
11-50
Industry
Biotechnology, Health Care, Medical Device
Bio
Dr Fanneau de La Horie has over 20 years of experience in the pharmaceutical and biotechnology industries. Before joining Pherecydes Pharma, he held a number of international management roles, including posts at Schering-Plough, Biogen and IDM, in both Europe and the US.
More recently, he was managing director of PathoQuest, a company developing a NGS-based infectious disease diagnostic technology. Between 2006 and 2013 he was the CEO of Neovacs and coordinated the 2010 IPO.
Prior to that, he spent eight years with Biogen, where he set up and ran the subsidiaries in France and Benelux. During his time with Biogen he managed the $700M salesforce in the US and held Europe-wide responsibilities for marketing, regulatory and medical affairs. A graduate of the National Veterinary School in Lyon, France (1982), Dr Fanneau de La Horie also holds an MBA from INSEAD, awarded in 1988.
Location
Romainville, Ile-de-France, France, Europe
Jobs history
0
N/A
Educations
1
N/A
Profile Resume
Guy Charles Fanneau de La Horie is the CEO at Pherecydes Pharma, based in Europe. With a background in Biotechnology, Guy Charles Fanneau de La Horie has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.